Myriad Genetics (MYGN) FCF Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly FCF Margin of 10.53% for Q1 2026, up 50.0% year-over-year from 7.02% in Q1 2025, and down 474.4% quarter-over-quarter from 2.81% in Q4 2025.
Myriad Genetics (MYGN) FCF Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported FCF Margin for 18 consecutive years, with 10.53% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 50.0% year-over-year to 10.53%; the TTM figure through Mar 2026 stood at 1.6% (up 211.0% YoY), while the FY2025 annual figure was 1.67%, up 163.0% from the prior year.
- FCF Margin eased to 10.53% in Q1 2026 per MYGN's latest filing, from 2.81% in the prior quarter.
- Across five years, FCF Margin topped out at 12.32% in Q2 2023 and bottomed at 32.02% in Q1 2022.
- Historically, FCF Margin has averaged 10.48% across 5 years, with a median of 10.53% in 2026.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 6940 bps — and 2023, when it jumped 4377 bps.
- Myriad Genetics' FCF Margin stood at 12.32% in 2022, then tumbled by 96 bps to 24.16% in 2023, then soared by 106 bps to 1.42% in 2024, then surged by 97 bps to 2.81% in 2025, then slumped by 474 bps to 10.53% in 2026.
- Business Quant data shows MYGN's FCF Margin at 10.53% in Q1 2026, 2.81% in Q4 2025, and 4.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 20.19% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -1.15% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.24% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.51% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | -5.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.45% |
| Mar 31, 2026 | -10.53% |
| Dec 31, 2025 | 2.81% |
| Sep 30, 2025 | 8.90% |
| Jun 30, 2025 | -7.70% |
| Mar 31, 2025 | -11.03% |
| Dec 31, 2024 | 1.42% |
| Sep 30, 2024 | -1.31% |
| Jun 30, 2024 | -1.23% |
| Mar 31, 2024 | -12.51% |
| Dec 31, 2023 | -32.91% |
| Sep 30, 2023 | -17.20% |
| Jun 30, 2023 | -10.74% |
| Mar 31, 2023 | -31.29% |
| Dec 31, 2022 | -12.32% |
| Sep 30, 2022 | -13.11% |
| Jun 30, 2022 | -31.46% |
| Mar 31, 2022 | -32.02% |
| Dec 31, 2021 | -8.02% |
| Sep 30, 2021 | -25.28% |